{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:31:20Z","timestamp":1783603880298,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,2,1]],"date-time":"1996-02-01T00:00:00Z","timestamp":823132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[1996,2]]},"DOI":"10.1016\/s0749-2081(96)80019-2","type":"journal-article","created":{"date-parts":[[2005,6,16]],"date-time":"2005-06-16T10:20:04Z","timestamp":1118917204000},"page":"59-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multiple myeloma"],"prefix":"10.1016","volume":"12","author":[{"given":"Carol A.","family":"Sheridan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0749-2081(96)80019-2_bib1","series-title":"American Cancer Society Textbook of Clinical Oncology","first-page":"470","article-title":"Multiple myeloma","author":"Bubbley","year":"1995"},{"key":"10.1016\/S0749-2081(96)80019-2_bib2","first-page":"20","article-title":"Management of multiple myeloma","volume":"32","author":"Alexanian","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib3","series-title":"Cancer Facts and Figures","year":"1996"},{"key":"10.1016\/S0749-2081(96)80019-2_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0268-960X(93)90020-5","article-title":"Multiple myeloma: The biology of malignant plasma cells","volume":"7","author":"Barker","year":"1993","journal-title":"Blood Rev"},{"key":"10.1016\/S0749-2081(96)80019-2_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0268-960X(93)90021-U","article-title":"Biology and treatment of multiple myeloma","volume":"7","author":"Niesvizky","year":"1993","journal-title":"Blood Rev"},{"key":"10.1016\/S0749-2081(96)80019-2_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1532-5415.1994.tb06866.x","article-title":"Multiple myeloma in the elderly","volume":"42","author":"Gautier","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S0749-2081(96)80019-2_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3949\/ccjm.61.4.285","article-title":"Multiple myeloma: An overview of diagnosis and management","volume":"61","author":"Hussein","year":"1994","journal-title":"Clev Clin J Med"},{"key":"10.1016\/S0749-2081(96)80019-2_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0889-8588(18)30341-1","article-title":"The epidemiology of multiple myeloma","volume":"6","author":"Riedel","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/S0749-2081(96)80019-2_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1353\/hpu.2010.0299","article-title":"The African American cancer crisis. I. The problem","volume":"4","author":"Clayton","year":"1993","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/S0749-2081(96)80019-2_bib10","series-title":"Principles and Practice of Hematology","first-page":"885","article-title":"Plasma cell diseases and related disorders in blood","author":"Shulman","year":"1995"},{"key":"10.1016\/S0749-2081(96)80019-2_bib11","series-title":"Cancer Nursing Principle and Practice (ed 3)","first-page":"1229","article-title":"Multiple myeloma","author":"Sheridan","year":"1993"},{"key":"10.1016\/S0749-2081(96)80019-2_bib12","first-page":"3","article-title":"Hematopoiesis: An overview","volume":"18","author":"DiJulio","year":"1991","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/S0749-2081(96)80019-2_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0011-5029(90)90013-H","article-title":"Myeloma","volume":"36","author":"Jacobs","year":"1990","journal-title":"Dis Mon"},{"key":"10.1016\/S0749-2081(96)80019-2_bib14","first-page":"417","article-title":"Biologic and clinical advances in multiple myeloma","volume":"9","author":"Varterasian","year":"1995","journal-title":"Oncology"},{"key":"10.1016\/S0749-2081(96)80019-2_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0889-8588(18)30348-4","article-title":"Diagnostic criteria of multiple myeloma","volume":"6","author":"Kyle","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/S0749-2081(96)80019-2_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0268-960X(94)90003-5","article-title":"Mechanisms of the escape phase of myeloma","volume":"8","author":"Joshua","year":"1994","journal-title":"Blood Rev"},{"key":"10.1016\/S0749-2081(96)80019-2_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hon.2900120303","article-title":"Recent progress in multiple myeloma","volume":"12","author":"Moscinski","year":"1994","journal-title":"Hematol Oncol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib18","first-page":"4","article-title":"Cytokine receptors, transduction signals and oncogenes in human multiple myeloma","volume":"32","author":"Klein","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2141.1990.tb06330.x","article-title":"The role of interleukin-1 and tumor necrosis-factor-a in human multiple myeloma","volume":"74","author":"Carter","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0889-8588(18)30345-9","article-title":"Mechanisms of bone lesions in multiple myeloma","volume":"6","author":"Bataille","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/S0749-2081(96)80019-2_bib21","series-title":"A Cancer Source Book for Nurses","first-page":"286","article-title":"The lymphomas and multiple myeloma","author":"Anderson","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0749-2081(90)90027-3","article-title":"Relevance of quality of life to clinical nursing practice","volume":"6","author":"Varricchio","year":"1990","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/S0749-2081(96)80019-2_bib23","first-page":"1039","article-title":"Hypercalcemia of malignancy: A review of advances in pathophysiology","volume":"21","author":"Kaplan","year":"1994","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/S0749-2081(96)80019-2_bib24","first-page":"210","article-title":"Hyperviscosity syndromes and coagulopathies","volume":"17","author":"Patterson","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib25","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/0277-5379(91)90020-E","article-title":"Changing clinical presentation of multiple myeloma","volume":"27","author":"Riccardi","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0749-2081(96)80019-2_bib26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199202063260607","article-title":"The many pitfalls of diagnosis of myeloma","volume":"326","author":"Duffy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0749-2081(96)80019-2_bib27","series-title":"Neoplastic Diseases of the Blood","first-page":"415","article-title":"Immunosuppression and infection in multiple myeloma","author":"Jacobson","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","article-title":"Biphasic pattern of bacterial infection in multiple myeloma","volume":"96","author":"Savage","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0749-2081(96)80019-2_bib29","first-page":"626","article-title":"Multiple myeloma presenting with Hemophilus influenza septic arthritis: Case report and review of the literature","volume":"85","author":"Berthaud","year":"1993","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/S0749-2081(96)80019-2_bib30","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/S0749-2081(96)80019-2_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.V55.3.364.364","article-title":"Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma","volume":"55","author":"Durie","year":"1980","journal-title":"Blood"},{"key":"10.1016\/S0749-2081(96)80019-2_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V75.4.823.823","article-title":"Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: A Southwest oncology group study","volume":"75","author":"Durie","year":"1990","journal-title":"Blood"},{"key":"10.1016\/S0749-2081(96)80019-2_bib33","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/1097-0142(19910615)67:12<3150::AID-CNCR2820671236>3.0.CO;2-U","article-title":"Prognostic factors on multiple myeloma","volume":"67","author":"Cherng","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/S0749-2081(96)80019-2_bib34","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/archinte.1990.00040031693017","article-title":"Renal failure in multiple myeloma pathogenesis and prognostic implications","volume":"150","author":"Alexanian","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0749-2081(96)80019-2_bib35","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1002\/1097-0142(19931201)72:11+<3489::AID-CNCR2820721616>3.0.CO;2-3","article-title":"Newer approaches to the management of multiple myeloma","volume":"72","author":"Kyle","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S0749-2081(96)80019-2_bib36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V80.3.733.733","article-title":"C-reative protein and B2 microglobulin produce a simple and powerful myeloma staging system","volume":"80","author":"Batille","year":"1992","journal-title":"Blood"},{"key":"10.1016\/S0749-2081(96)80019-2_bib37","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/0959-8049(93)90071-M","article-title":"Karotype in multiple myeloma and plasma cell leukemia","volume":"29","author":"Weh","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0749-2081(96)80019-2_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1200\/JCO.1992.10.2.334","article-title":"Combination chemotherapy versus melphalan and prednisone in the treatment of multiple myeloma: An overview of published trials","volume":"10","author":"Gregory","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib39","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/jama.1969.03160090040009","article-title":"Treatment for multiple myeloma: Combination chemotherapy with different melphalan dose regimens","volume":"208","author":"Alexanian","year":"1969","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S0749-2081(96)80019-2_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V67.2.275.275","article-title":"Treatment of multiple myeloma with recombinant alpha interferon","volume":"67","author":"Quesada","year":"1986","journal-title":"Blood"},{"key":"10.1016\/S0749-2081(96)80019-2_bib41","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V81.6.1428.1428","article-title":"Natural interferon-a in combination with melphalan\/prednisone in the treatment of multiple myeloma stages II and III: A randomized study from myeloma group of Central Sweden","volume":"81","author":"Osterberg","year":"1993","journal-title":"Blood"},{"issue":"Suppl 14","key":"10.1016\/S0749-2081(96)80019-2_bib42","first-page":"14","article-title":"Innovative treatment strategies for non-hodgkin's lymphoma and multiple myeloma","volume":"21","author":"Borden","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib43","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1200\/JCO.1994.12.11.2405","article-title":"Combination chemotherapy, glucocorticoids and interferon alpha in the treatment of multiple myeloma: A Southwest Oncology Group Study","volume":"12","author":"Salmon","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib44","series-title":"Cancer Nursing: Principles and Practice (ed 3)","first-page":"366","article-title":"Biotherapy","author":"Jassak","year":"1993"},{"key":"10.1016\/S0749-2081(96)80019-2_bib45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.1992.10.4.587","article-title":"Curability of solitary bone plasmacytoma","volume":"10","author":"Dimopoulos","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib46","series-title":"Cancer Nursing: Principles and Practice (ed 3)","first-page":"235","article-title":"Radiotherapy","author":"Hilderley","year":"1993"},{"key":"10.1016\/S0749-2081(96)80019-2_bib47","first-page":"432","article-title":"Radiotherapy for cancer pain management","volume":"2","author":"Janjan","year":"1994","journal-title":"Hematol Oncol Ann"},{"issue":"suppl 6","key":"10.1016\/S0749-2081(96)80019-2_bib48","first-page":"67","article-title":"Allogeneic bone marrow transplantation for multiple myeloma","volume":"20","author":"Ballester","year":"1993","journal-title":"Semin Oncol"},{"issue":"suppl 4","key":"10.1016\/S0749-2081(96)80019-2_bib49","first-page":"33","article-title":"Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide","volume":"20","author":"Copelan","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0889-8588(18)30354-X","article-title":"Allogeneic bone marrow transplantation in multiple myeloma","volume":"6","author":"Tura","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/S0749-2081(96)80019-2_bib51","first-page":"31","article-title":"Autologous and allogeneic transplants for multiple myeloma","volume":"32","author":"Barlogie","year":"1995","journal-title":"Semin Hematol"},{"key":"10.1016\/S0749-2081(96)80019-2_bib52","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199110313251802","article-title":"Allogeneic bone marrow transplantation in multiple myeloma","volume":"325","author":"Gahrton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S0749-2081(96)80019-2_bib53","series-title":"Cancer Nursing: Principles and Practice","first-page":"1149","article-title":"Leukemia","author":"Wujcik","year":"1993"},{"key":"10.1016\/S0749-2081(96)80019-2_bib54","series-title":"Guidelines","first-page":"125","article-title":"Alteration in comfort: Acute pain","author":"Paice","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib55","series-title":"Guidelines for Oncology Nursing Practice","first-page":"131","article-title":"Alteration in comfort: Chronic pain","author":"Willoughby","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0029-6465(22)02776-1","article-title":"Interventions related to patients safety","volume":"27","author":"Kanak","year":"1992","journal-title":"Nurs Clin North Am"},{"key":"10.1016\/S0749-2081(96)80019-2_bib57","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0029-6465(22)02992-9","article-title":"Psychologic aspects of depression","volume":"25","author":"Buckwalter","year":"1990","journal-title":"Nurs Clin North Am"},{"key":"10.1016\/S0749-2081(96)80019-2_bib58","first-page":"1337","article-title":"Neurologic complications of immunosuppressive cancer therapy","volume":"20","author":"Furlong","year":"1993","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/S0749-2081(96)80019-2_bib59","first-page":"9","article-title":"Putting the Cancer Pain Guidelines into Practice","volume":"3","author":"Miakowski","year":"1995","journal-title":"Caps Comm Oncol Nurs"},{"key":"10.1016\/S0749-2081(96)80019-2_bib60","first-page":"1507","article-title":"Nursing care of the patient with spinal cord compression","volume":"20","author":"Held","year":"1993","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/S0749-2081(96)80019-2_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0749-2081(05)80085-3","article-title":"Selected complications in the patient with cancer: Spinal cord compression, malignant bowel obstruction, malignant ascites and gastrointestinal bleeding","volume":"10","author":"Labovich","year":"1994","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/S0749-2081(96)80019-2_bib62","series-title":"Guidelines for Oncology Nursing Practice","first-page":"191","article-title":"Potential for infection","author":"McNally","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib63","series-title":"Guidelines for Oncology Nursing Practice","first-page":"203","article-title":"Potential for injury related to thrombocytopenia","author":"Alexander","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib64","series-title":"Guidelines for Oncology Nursing Practice","first-page":"208","article-title":"Potential for injury related to anemia","author":"Rostad","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib65","series-title":"Current Issues in Cancer Nursing Practice Updates","first-page":"1","article-title":"The application of hematopoietic colony stimulating factors in cancer management","author":"Applebaum","year":"1993"},{"key":"10.1016\/S0749-2081(96)80019-2_bib66","first-page":"295","article-title":"Drug therapy management of the febrile neutropenic cancer patient","volume":"1","author":"Finkbiner","year":"1993","journal-title":"Cancer Pract"},{"key":"10.1016\/S0749-2081(96)80019-2_bib67","first-page":"71","article-title":"A new approach to managing chemotherapy related anemia: Nursing implications of epoetin alfa","volume":"22","author":"Rieger","year":"1995","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/S0749-2081(96)80019-2_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002820-199502000-00004","article-title":"Fatigue reducing strategies used by patients receiving treatment for cancer","volume":"18","author":"Graydon","year":"1995","journal-title":"Cancer Nurs"},{"key":"10.1016\/S0749-2081(96)80019-2_bib69","series-title":"Guidelines for Oncology Nursing Practice","first-page":"297","article-title":"Alteration in bowel elimination: Constipation","author":"French","year":"1991"},{"key":"10.1016\/S0749-2081(96)80019-2_bib70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0749-2081(05)80084-1","article-title":"Heart, lung and endocrine complications of solid tumors","volume":"10","author":"Shuey","year":"1994","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/S0749-2081(96)80019-2_bib71","first-page":"1201","article-title":"A meta-analysis of intervention effectiveness for symptom management in oncology nursing research","volume":"21","author":"Smith","year":"1994","journal-title":"Oncol Nurs Forum"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208196800192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208196800192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:42:34Z","timestamp":1760082154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208196800192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,2]]}},"alternative-id":["S0749208196800192"],"URL":"https:\/\/doi.org\/10.1016\/s0749-2081(96)80019-2","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[1996,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0749-2081(96)80019-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}